{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:28:49Z","timestamp":1749144529232,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02329-y","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T06:03:01Z","timestamp":1652248981000},"page":"3303-3309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical profile and management outcomes of posterior zone 1 retinopathy of prematurity"],"prefix":"10.1007","volume":"42","author":[{"given":"Anusha","family":"Sachan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-1410","authenticated-orcid":false,"given":"Parijat","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chandra Lakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja Rajesh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"issue":"11","key":"2329_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1136\/bjo.2006.102038","volume":"90","author":"RJ Hardy","year":"2006","unstructured":"Hardy RJ, Good WV, Dobson V, Palmer EA, Tung B, Phelps DL et al (2006) the early treatment for retinopathy of prematurity clinical trial: presentation by subgroups versus analysis within subgroups. Br J Ophthalmol 90(11):1341\u20131342","journal-title":"Br J Ophthalmol"},{"issue":"7 Suppl","key":"2329_CR2","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/01.iae.0000244285.79004.e6","volume":"26","author":"A Kychenthal","year":"2006","unstructured":"Kychenthal A, Dorta P, Katz X (2006) Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes. Retina 26(7 Suppl):S11-15","journal-title":"Retina"},{"issue":"4","key":"2329_CR3","first-page":"1140","volume":"35","author":"D Kumawat","year":"2021","unstructured":"Kumawat D, Sachan A, Shah P, Chawla R, Chandra P (2021) Aggressive posterior retinopathy of prematurity: a review on current understanding. Eye Lond Engl 35(4):1140\u20131158","journal-title":"Eye Lond Engl"},{"unstructured":"Guidelines for Universal Eye Screening in Newborns Including Retinopathy of Prematurity [Internet]. Rashtriya bal swasthya karyakram; 2017 [cited 2021 Apr 1]. Available from: https:\/\/www.nhm.gov.in\/images\/pdf\/programmes\/RBSK\/Resource_Documents\/Revised_ROP_Guidelines-Web_Optimized.pdf - Google Search [Internet]. [cited 2021 Apr 18]","key":"2329_CR4"},{"issue":"5","key":"2329_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/archopht.120.5.595","volume":"120","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"2002","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group (2002) Multicenter trial of cryotherapy for retinopathy of prematurity: natural history rop\u2014ocular outcome at 5\u00bd Years in premature infants with birth weights less than 1251 g. Arch Ophthalmol 120(5):595. https:\/\/doi.org\/10.1001\/archopht.120.5.595","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"2329_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603\u201315","journal-title":"N Engl J Med"},{"issue":"10208","key":"2329_CR7","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","volume":"394","author":"A Stahl","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A, Fleck B, Reynolds JD, Chiang MF et al (2019) Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet Lond Engl 394(10208):1551\u20131559","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"2329_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jcjo.2018.03.005","volume":"54","author":"D Katoch","year":"2019","unstructured":"Katoch D, Dogra MR, Aggarwal K, Sanghi G, Samanta R, Handa S et al (2019) Posterior zone I retinopathy of prematurity: spectrum of disease and outcome after laser treatment. Can J Ophthalmol 54(1):87\u201393","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"2329_CR9","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","volume":"115","author":"C Gilbert","year":"2005","unstructured":"Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P et al (2005) Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 115(5):e518-525","journal-title":"Pediatrics"},{"issue":"8","key":"2329_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12098-009-0175-1","volume":"76","author":"PK Shah","year":"2009","unstructured":"Shah PK, Narendran V, Kalpana N, Gilbert C (2009) Severe retinopathy of prematurity in big babies in India: history repeating itself? Indian J Pediatr 76(8):801\u2013804","journal-title":"Indian J Pediatr"},{"issue":"4","key":"2329_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ajo.2010.10.007","volume":"151","author":"S Jalali","year":"2011","unstructured":"Jalali S, Kesarwani S, Hussain A (2011) Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin cities rop screening program report number 2. Am J Ophthalmol 151(4):719-724.e2","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2329_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4103\/0301-4738.128639","volume":"62","author":"G Sanghi","year":"2014","unstructured":"Sanghi G, Dogra MR, Katoch D, Gupta A (2014) Aggressive posterior retinopathy of prematurity in infants \u22651500 g birth weight. Indian J Ophthalmol 62(2):254\u2013257","journal-title":"Indian J Ophthalmol"},{"key":"2329_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/808639","volume":"2015","author":"HK Pandya","year":"2015","unstructured":"Pandya HK, Faia LJ, Robinson J, Drenser KA (2015) Macular development in aggressive posterior retinopathy of prematurity. BioMed Res Int 2015:808639","journal-title":"BioMed Res Int"},{"issue":"7","key":"2329_CR14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.18240\/ijo.2019.07.15","volume":"12","author":"Q-Y Meng","year":"2019","unstructured":"Meng Q-Y, Cheng Y, Zhao M-W, Liang J-H (2019) The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China. Int J Ophthalmol 12(7):1146\u20131150","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"2329_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/eye.2015.240","volume":"30","author":"TR Padhi","year":"2016","unstructured":"Padhi TR, Das T, Rath S, Pradhan L, Sutar S, Panda KG et al (2016) Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I. Eye 30(3):392\u2013399","journal-title":"Eye"},{"issue":"1","key":"2329_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/IAE.0000000000001125","volume":"37","author":"JM Yoon","year":"2017","unstructured":"Yoon JM, Shin DH, Kim SJ, Ham D-I, Kang SW, Chang YS et al (2017) Outcomes after laser versus combined laser and bevacizumab treatment for type 1 retinopathy of prematurity in zone I. Retina Phila Pa 37(1):88\u201396","journal-title":"Retina Phila Pa"},{"issue":"4 Suppl","key":"2329_CR17","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/IAE.0b013e3181ca146b","volume":"30","author":"A Kychenthal","year":"2010","unstructured":"Kychenthal A, Dorta P (2010) Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Retina 30(4 Suppl):S32-36","journal-title":"Retina"},{"issue":"5","key":"2329_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10384-012-0141-8","volume":"56","author":"HJ Sun","year":"2012","unstructured":"Sun HJ, Choi KS, Lee SJ (2012) Adjunctive effect of intravitreal bevacizumab prior to lens-sparing vitrectomy in aggressive posterior retinopathy of prematurity: a case report. Jpn J Ophthalmol 56(5):476\u2013480","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"2329_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3928\/01913913-20191030-01","volume":"57","author":"P Chandra","year":"2020","unstructured":"Chandra P, Kumawat D, Agarwal D, Chawla R (2020) Combined vitrectomy and Anti-VEGF treatment for stage 4 retinopathy of prematurity with extensive neovascular proliferation. J Pediatr Ophthalmol Strabismus 57(1):61\u201366","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"7 Suppl","key":"2329_CR20","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1097\/01.iae.0000244288.63757.be","volume":"26","author":"CR Gonzales","year":"2006","unstructured":"Gonzales CR, Boshra J, Schwartz SD (2006) 25-Gauge pars plicata vitrectomy for stage 4 and 5 retinopathy of prematurity. Retina 26(7 Suppl):S42-46","journal-title":"Retina"},{"issue":"9","key":"2329_CR21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.ophtha.2005.03.031","volume":"112","author":"RR Lakhanpal","year":"2005","unstructured":"Lakhanpal RR, Sun RL, Albini TA, Holz ER (2005) Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Ophthalmology 112(9):1569\u20131573","journal-title":"Ophthalmology"},{"issue":"10","key":"2329_CR22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archophthalmol.2011.253","volume":"129","author":"W-C Wu","year":"2011","unstructured":"Wu W-C, Lai C-C, Lin R-I, Wang N-K, Chao A-N, Chen K-J et al (2011) Modified 23-gauge vitrectomy system for stage 4 retinopathy of prematurity. Arch Ophthalmol 129(10):1326\u201331","journal-title":"Arch Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02329-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02329-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T18:07:42Z","timestamp":1666462062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02329-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["2329"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02329-y","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"29 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This  retrospective review involving human participants was done in accordance with\u00a0the ethical standards (and approval) of the institutional research committee and\u00a0the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}